Facilities and Instruments
In the CRS there is a state-of-art GMP facility for the production of radiopharmaceuticals under good manufacturing practice (GMP) for clinical applications.
The CRS has a preclinical nuclear imaging facility in house. Both, single photon emission computed tomography (SPECT), and positron emission tomography (PET) with an anatomic imaging modality by computed tomography (CT). These instrumentations give us the ability to analyze and visualize biologically significant events (such as tumor growth, hypoxia, angiogenesis, apoptosis) in combination with the anatomical information provided by CT.
For more information, please contact Dr. Martin Béhé.
The sensitivity and resolution of liquid chromatography/electrospray ionization time-of-flight mass spectrometry (LCT Premier Mass Spectrometer, Waters AG) allows the determining of mass of peptides or proteins.
For more information, please contact Alain Blanc.